Biopol Chemicals Ltd.

NSE: BIOPOL

Biopol Chemicals Live Share Price Today, Share Analysis and Chart

Name: Biopol Chemicals Ltd.: Is Infosys Ltd. worth buying?
Item: Biopol Chemicals Ltd.
Rating: 1.42733325
Author: Trendlyne DVM scores

aboutBiopol Chemicals Ltd. (commonly identified as Biofil Chemicals & Pharmaceuticals Ltd. in regulatory filings) is an Indian chemical and pharmaceutical manufacturing entity. The company operates through two primary business divisions: a pharmaceutical ... Read More

1.85(4.14%)

12,000

NSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Biopol Chemicals is on 05 Nov 2026 for the purpose of Quarterly Results and Other business matters See details

- / 100

27.8 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

5Positive9Negative

35.7%Pass in checklist

045

100

Check P/E Buy Sell Zone

Not enough data available

Biopol Chemicals Stock Price Analysis

Day Price Range 4.1% 1 Day return	46.5 (LTP) 44.546.5 LowHigh
Week Price Range 10.4% 1 Week return	46.5 (LTP) 4347 LowHigh
Month Price Range -13.9% 1 Month return	46.5 (LTP) 42.156.7 LowHigh
52 Week Price Range -56.9% 1 Year return	46.5 (LTP) 39.5133.8 LowHigh

View full Price History/Seasonality

Competitors/Peers

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Biopol Chemicals annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Biopol Chemicals Mar-2026 Annual Revenue is Rs 81 Cr which is growth of 65.6% YoY.
POSITIVE
Annual Net Profit Biopol Chemicals Mar-2026 Annual Net Profit is Rs 9 Cr which is growth of 107.2% YoY.

Biopol Chemicals Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23
SR_A Total Rev. Ann. ⌄	61.6%	81.4	49.2	25.5	19.3
TotalOperatingRevenues_A Operating Rev. Ann.	61.4%	81.1	49.1	25.5	19.3
OI_A Other Income Ann.	-	0.2	0		0
OEXPNS_A Operating Exp. Ann.	56.1%	67.7	42.6	21	17.8
OEXPNS_A Operating Exp. Ann.	56.1%	67.7	42.6	21	17.8
OP_A Operating Profit Ann.	103.6%	13.5	6.5	4.4	1.6
OPMPCT_A OPM Ann. %	27.1%	16.53%	13.29%	17.38%	8.06%
TotalExpenses_A Total Exp. Ann. ⌄	55%	69.3	43.4	21.5	18.6
OtherExpenses_A Other Exp. Ann.	58.7%	2.8	0.8	1.5	0.7
EmployeeBenefitExpenses_A Employee Exp. Ann.	65.1%	1.8	1.1	0.5	0.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-
CostOfFuel_A Cost Of Fuel Ann.	-
EBIDT_A EBITDA Ann.	104.6%	13.7	6.6	4.4	1.6
EBIDTPCT_A EBITDA Ann. margin %	27.6%	16.81%	13.34%	17.38%	8.09%
INT_A Interest Ann.	23.3%	1.5	0.7	0.4	0.8
DEP_A Depr.	0%	0.1	0.1	0.1	0.1
PBT_A PBT Ann.	158.6%	12.1	5.8	4	0.7
TAX_A Tax Ann.	149.3%	3.1	1.5	1	0.2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	162.1%	9	4.3	3	0.5
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-
NP_A Net Profit Ann.	162.1%	9	4.3	3	0.5
NETPCT_A NPM Ann. %	59.6%	11.05%	8.81%	11.63%	2.72%
EPS_adj_A EPS Adj. latest Ann.	155.1%	8.3	4	2.7	0.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

65.4%

2Y CAGR

78.7%

3Y CAGR

61.6%

Net Profit Ann.

1Y CHG

109.3%

2Y CAGR

73.2%

3Y CAGR

162.1%

Operating Exp. Ann.

1Y CHG

58.9%

2Y CAGR

79.5%

3Y CAGR

56.1%

Biopol Chemicals Technical Analysis

Biopol Chemicals EMA & SMA

Bearish-1

3 bullish, 4 bearish

Bullish3

Bearish4

5 Day	45.0
10 Day	45.4
12 Day	45.7
20 Day	47.3

26 Day	48.9
50 Day	57.0
100 Day	70.6

Biopol Chemicals Delivery And Volume

Daily Avg. Delivery Volume %

30 Oct, 2026100.0%

Week90.0%

Month84.5%

Biopol Chemicals Active Candlesticks

Marubozu Uptrend Belt Hold Uptrend Closing Marubozu Uptrend Inside Uptrend Long Line Uptrend

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Biopol Chemicals Resistance and Support

45.83

Pivot

First Resistance	47.2
Second Resistance	47.8
Third Resistance	49.2

First Support	45.2
Second Support	43.8
Third Support	43.2

Day RSI	43.9
Day MACD	-3.1
Day MFI	31.4
Day MACD Signal Line	-3.6

Biopol Chemicals Beta

1 Month	-0.1
1 Year	-

3 Month	0.5
3 Year	-

Biopol Chemicals Price Change Analysis

↓-13.9%

Over 1 Month

LowHigh

42.156.7

↓-54.4%

Over 3 Months

LowHigh

39.5105

↓-60.2%

Over 6 Months

LowHigh

39.5133.8

↓-56.9%

Over 1 Year

LowHigh

39.5133.8

Biopol Chemicals Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Santanu Sarkar	Promoter	6,930,500	64.1 %
Kingsman Wealth Management Private Limited	Public	600,000	5.6 %

HISTORICAL PROMOTER HOLDING

Promoters holding remains unchanged at 65.81% in Sep 2026 qtr

HISTORICAL FII HOLDING

FII/FPI have decreased holdings from 4.70% to 0.47% in Sep 2026 qtr

HISTORICAL MF HOLDING

All Shareholding details

Biopol Chemicals Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
NEO APEX SHARE BROKING SERVICES LLP	Bulk	Sell	03 Sep 2026	41.38	70,800	NSE
NEO APEX SHARE BROKING SERVICES LLP	Bulk	Purchase	03 Sep 2026	39.64	33,600	NSE
NEO APEX SHARE BROKING SERVICES LLP	Bulk	Sell	02 Sep 2026	41.55	57,600	NSE
NEO APEX SHARE BROKING SERVICES LLP	Bulk	Purchase	01 Sep 2026	46.15	94,800	NSE
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	Sell	31 Aug 2026	51.36	66,000	NSE
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	Purchase	31 Aug 2026	51.28	88,800	NSE
CRAFT EMERGING MARKET FUND PCC-CITADEL CAPITAL FUND	Bulk	Sell	24 Aug 2026	98.90	120,000	NSE
BEACON STONE CAPITAL VCC - BEACON STONE I	Bulk	Sell	21 Aug 2026	99.89	118,800	NSE
DHANESH RASIKLAL SHAH	Bulk	Sell	14 Aug 2026	93.14	90,000	NSE
SINGASANDRA NAGAPPA MAHADEVA	Bulk	Sell	10 Aug 2026	104.95	67,200	NSE

All deals

All insider trades

Biopol Chemicals Corporate Actions

Biopol Chemicals Board Meetings

Biopol Chemicals past and upcoming board meetings.

#Ex-Date	Purpose	Notes
105 Nov 2026	Quarterly Results and Other business matters	To approve financial results for the period ended September 30, 2026, and other matters.
230 Apr 2026	Audited Results	-

All Corporate Actions

Biopol Chemicals - Company Profile

Biopol Chemicals Management Structure

Biopol Chemicals management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF
Mr. Vandan Vij Sarkar	Head(Operation.,Management.)	6.5	Mar 26
Mr. Rajat Chowdhury	President(Planning,Procurement)	5.6	Mar 26
Mr. Subhradeep Mah Anta	Manager(Imports)	4.38	Mar 26
Mr. Sandip Choudhury	Chief Financial Officer	3.77	Mar 26
Mr. Rawal Krishna Haresh	Admin Staff(Accounts)	3.6	Mar 26
Mr. Joyanta Kumar Mitra	Business Development Manager	3.44	Mar 26
Mr. Apurba Mallik	Senior Manager(Technical)	3	Mar 26
Mr. Sankar Paul	Laboratory Assistant	2.89	Mar 26
Mr. Santu Ghosh	Machine Operator	2.67	Mar 26
Mr. Hunti Bakordor Kharlukhi	Manager(Human Resources)	2.27	Mar 26
Mr. Manotosh Debnath	Marketing Executive	2.15	Mar 26
Deepti Nama	Company Secretary,Compliance Officer	1.75	Mar 26

Biopol Chemicals Board of Directors

Biopol Chemicals Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Santanu Sarkar	Chairman & Managing Director	48	Mar 25
Vedant Sarkar	Whole-time Director	12	Mar 25
Preety Priya Ghosh	Independent Non Exe. Director	-	Mar 25
Gaurav Mittal	Independent Non Exe. Director	-	Mar 25
Mr. Kaushikkumar Vasantbhai Darji	Independent Non Exe. Director	-	Mar 25
Deepti Nama	Company Sec. & Compli. Officer	-	Mar 25

About

Website: biopolchemicals.com/

About the company - Business Profile

Biopol Chemicals Ltd. (commonly identified as Biofil Chemicals & Pharmaceuticals Ltd. in regulatory filings) is an Indian chemical and pharmaceutical manufacturing entity. The company operates through two primary business divisions: a pharmaceutical manufacturing unit and a chemical production division. It serves industrial and healthcare sectors by providing active pharmaceutical ingredients (APIs), finished formulations, and chemical intermediaries.

Key Points

Key Facts: Founded in 1985, the company is headquartered in Indore, Madhya Pradesh. It is listed on the BSE and NSE under the ticker BIOFILCHEM. The management is led by Ketan Shah, who serves as the Chairman and Managing Director.
Operations and Resources: The company operates a dedicated Pharma Unit and a Chemicals Division. Its registered office and manufacturing infrastructure are located in the Industrial Estate of Indore.
Privatization and Ownership: The company is a publicly listed entity with significant promoter holdings. As of recent filings, the leadership remains under the Shah family.
Market and Significance: Biopol Chemicals caters to both domestic and international markets, supplying essential chemical components for plastic additives and pharmaceutical formulations. It holds a strategic position in the MSME sector for healthcare manufacturing.
Sustainability and Innovation: The company focuses on improving process reliability and maintaining compliance with manufacturing standards (such as GMP). Recent initiatives include structural upgrades to manufacturing blocks to align with global quality audits.

Business Model and Financial Performance

The company follows a diversified manufacturing business model, leveraging its dual-segment structure to mitigate industry-specific risks. Its core competency lies in the manufacturing of basic chemicals and pharmaceutical products.

Revenue Breakdown (FY 2024-25 Annual Data):

Total Revenue from Operations: ₹3,340.22 Lakhs
Pharma Unit: ₹2,666.01 Lakhs (Approximately 79.8% of total revenue)
Chemicals Division: ₹674.18 Lakhs (Approximately 20.2% of total revenue)

Geographical and Operational Results:

Total Segment Profit Before Tax: ₹72.81 Lakhs (FY 2024-25)
Pharma Unit Profitability: While the segment generates high revenue, it reported a marginal loss before tax of ₹14.38 Lakhs for FY 2024-25.
Chemicals Division Profitability: Contributed ₹87.19 Lakhs to the profit before tax in the same period.
Capital Employed: The total capital employed as of March 31, 2025, stood at ₹1,878.16 Lakhs, with the Chemicals Division accounting for ₹1,325.62 Lakhs and the Pharma Division ₹552.54 Lakhs.

Strategic Initiatives and Outlook

The company is currently undergoing layout modifications and civil upgrades for its manufacturing blocks to ensure compliance with EU-GMP standards. This move is aimed at expanding its export client base and meeting international quality benchmarks. For the half-year ended September 30, 2025, the company showed significant growth, with total revenue reaching ₹1,997.34 Lakhs compared to ₹1,085.60 Lakhs in the previous year's corresponding period. Management remains focused on cost efficiency and technological upgrades to navigate volatile raw material prices and global supply chain disruptions.

References

Biopol Chemicals FAQ

Biopol Chemicals today is trading in the green, up by 4.14% at ₹46.5.

Biopol Chemicals is currently trading up 4.14% on an intraday basis. In the past week the stock rose 10.45%. Stock has been down 54.39% in the past quarter and fell 56.94% in the past year. You can view this in the share price history/seasonality section.

Biopol Chemicals is listed on NSE with the ticker BIOPOL. It's currently trading on NSE at a share price of ₹46.5.

The market cap of Biopol Chemicals is ₹50.25 Cr. as of Oct 30, 2026.

Biopol Chemicals has never announced any dividend since the time of its listing on the NSE exchange.

Biopol Chemicals has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

Biopol Chemicals reported ₹81.37 Cr. in revenue, ₹8.97 Cr. in net profit, and ₹13.68 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for Biopol Chemicals.

The PE ratio of Biopol Chemicals is 5.6 as of Oct 30, 2026.

The PB ratio of Biopol Chemicals is 1.01 as of Oct 30, 2026.

There are no analyst reports for Biopol Chemicals.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Biopol Chemicals Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Biopol Chemicals Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Biopol Chemicals - Annual

Biopol Chemicals annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Biopol Chemicals Mar-2026 Annual Revenue is Rs 81 Cr which is growth of 65.6% YoY.

Annual Net Profit Biopol Chemicals Mar-2026 Annual Net Profit is Rs 9 Cr which is growth of 107.2% YoY.

Biopol Chemicals Technical Analysis

Biopol Chemicals EMA & SMA

Biopol Chemicals Delivery And Volume

Biopol Chemicals Active Candlesticks

Biopol Chemicals Resistance and Support

Biopol Chemicals Beta

Biopol Chemicals Price Change Analysis

Biopol Chemicals Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Biopol Chemicals Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Biopol Chemicals Corporate Actions

Biopol Chemicals Board Meetings

Biopol Chemicals past and upcoming board meetings.

Biopol Chemicals - Company Profile

Biopol Chemicals Management Structure

Biopol Chemicals management structure with salaries, total experience, and qualifications.

Biopol Chemicals Board of Directors

Biopol Chemicals Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Key Points

Business Model and Financial Performance

Strategic Initiatives and Outlook

Biopol Chemicals FAQ

How is Biopol Chemicals today?

Biopol Chemicals today is trading in the green, up by 4.14% at ₹46.5.

How has Biopol Chemicals performed historically?

Biopol Chemicals is currently trading up 4.14% on an intraday basis. In the past week the stock rose 10.45%. Stock has been down 54.39% in the past quarter and fell 56.94% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Biopol Chemicals on NSE and BSE exchanges?

Biopol Chemicals is listed on NSE with the ticker BIOPOL. It's currently trading on NSE at a share price of ₹46.5.

What is the market cap of Biopol Chemicals?

The market cap of Biopol Chemicals is ₹50.25 Cr. as of Oct 30, 2026.

When did Biopol Chemicals last pay a dividend, and what has its dividend history been?

Biopol Chemicals has never announced any dividend since the time of its listing on the NSE exchange.

Has Biopol Chemicals issued any bonus shares or share splits recently?

Biopol Chemicals has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

What do the financial statements and annual reports of Biopol Chemicals Indicate?

Biopol Chemicals reported ₹81.37 Cr. in revenue, ₹8.97 Cr. in net profit, and ₹13.68 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of Biopol Chemicals according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Biopol Chemicals.

What is the PE Ratio of Biopol Chemicals?

The PE ratio of Biopol Chemicals is 5.6 as of Oct 30, 2026.

What is the PB Ratio of Biopol Chemicals?

The PB ratio of Biopol Chemicals is 1.01 as of Oct 30, 2026.

Where can I check the latest Research Reports about Biopol Chemicals?

There are no analyst reports for Biopol Chemicals.

How can I be notified of real time alerts about Biopol Chemicals stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.